|Ticker||Company name||Industry||Market Cap
|Dividend Yield||Dividend Frequency||Stock price||Currency||Stock Exchange|
|LONN||Lonza Group AG||Healthcare||40.99||0.5 %||Annual||551.8||CHF||SIX Swiss Exchange|
Company's Past Performance
The 5 years average P/E ratio is the average of each year’s P/E ratios. P/E ratio in any year is limited to 30 in order to reduce the effect of the extreme values on the average P/E.
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It provides value chemical and biotech ingredients to the nutrition and agro markets. The company operates its business through two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech segment provides pharmaceutical ingredients and biopharmaceuticals as well as research and testing products and services. The Specialty Ingredients segment provides solutions that promote health, wellness, beauty, nutrition, hygiene and materials protection. The company was founded in 1897 and is headquartered in Basel, Switzerland.